My Cart [ 0 ]
Home > Proteins & Peptides > A-Z Proteins  > VHL Protein

VHL Protein

Von Hippel-Lindau disease tumor suppressor, pVHL, Protein G7, RCA1, VHL1, HRCA1

Catalog No. Product Name Size List Price (US$) Quantity
BP002095-PRO-440 Recombinant Human VHL Protein 50 ug 160.00
BP002095-PRO-440 Recombinant Human VHL Protein 1 mg 1800.00
Description

Introduction
Von Hippel-Lindau disease is a dominant inherited syndrome characterized by the predisposition to develop various kinds of benign and malignant tumors, including clear cell renal carcinomas, pheochromocytomas and hemangioblastomas of the central nervous system and retina. VHL syndrome is caused by germline mutation in the VHL tumor suppressor, and VHL tumors are associated with loss or mutation of the remaining wild-type allele. VHL has two domains: a roughly 100-residue NH2-terminal domain rich in b sheet (b-domain) and a smaller a-helical domain (a-domain), held together by two linkers and a polar interface. VHL protein is also involved in the degradation of hypoxia-inducible factor (HIF).

BP002095-PRO-440: Recombinant Human Von Hippel-Lindau disease tumor suppressor (VHL) Protein

Source: E. coli-derived.
Recombinant Human Von Hippel-Lindau disease tumor suppressor (VHL) Protein is a single, non-glycosylated polypeptide chain containing 174 amino acids (1-154) & having a molecular mass of 19.2 kDa. The Von Hippel-Lindau antigen is fused to 20 amino acid His-Tag at N-terminus and purified by proprietary chromatography techniques.
Purity: > 95% as determined by SDS-PAGE.
Formulation: The Von Hippel-Lindau Protein contains 1x PBS pH 7.4, 2 mM EDTA, and 1 mM DTT.

Shipping: The product is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.

VHL Antibodies:
VHL Monoclonal Antibody
VHL (Ab-68) Polyclonal Antibody

Related Links

See our Privacy Policy